Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data
Профилактика гипогликемии посредством снижения подачи инсулиновой помпы и использования красно-жёлто-зелёных «светофорных» сигналов на основе данных непрерывного мониторинга глюкозы и инсулиновой помпы
2010-09-01
SCID: 54.1/a64c9e94
Discuss with AI
continuous glucose monitoringcontrol-to-range architecturehypoglycemia preventioninsulin pump attenuationmetabolic state observer
Figures from the paper
Abstract (AI)
BACKGROUND: Hypoglycemia has been identified as a primary barrier to optimal management of diabetes. This observation, in conjunction with the introduction of continuous glucose monitoring (CGM) devices, has set the stage for achieving tight glycemic control with systems that adjust the insulin pump settings based on measured glucose concentrations. Because system safety and system reliability are key considerations, there is a need for algorithms that reduce the risk of hypoglycemia in closed-loop, open-loop, and advisory-mode systems. More specifically, the algorithm presented here is formulated as a component of the independent safety system module proposed in the modular control-to-range architecture. METHODS: We developed two algorithms for attenuating insulin pump injections, which we refer to as Brakes and Power Brakes: Brakes is a pump attenuation function computed using CGM information only, while Power Brakes is an attenuation function in which a metabolic state observer with insulin input is used in addition to CGM information to inform the level of pump attenuation. These algorithms modulate the insulin pump delivery so that the insulin injection rate is dramatically reduced when the risk of hypoglycemia is high. Additionally, we combined these algorithms with an alert system that indicates a level of hypoglycemic risk to the user. RESULTS: We demonstrated the effectiveness of Brakes and Power Brakes in reducing the incidence of hypoglycemia in two simulated scenarios: an elevated basal rate scenario and a scenario in which a bolus is delivered for a meal that is skipped. For these scenarios, the incidence of hypoglycemia using Power Brakes was reduced by 88 and 94%, respectively, where we defined hypoglycemia based on the American Diabetes Association guidelines for defining and reporting as 70 mg/dl. In the elevated basal rate scenario, no rebounds above 180 mg/dl (the desired upper limit of the control-to-range protocol) following hypoglycemia were shown to occur. We demonstrated the way the hypoglycemia alert system can trigger the intake of carbohydrates to reduce the incidence of hypoglycemia by 98%. CONCLUSIONS: This article offers, for the first time, a method for smoothly reducing insulin delivery rate to prevent hypoglycemia in individuals with type 1 diabetes mellitus based on a mathematically formal assessment of hypoglycemic risk. In silico, we demonstrate the way this method can prevent hypoglycemia while avoiding hyperglycemia rebounds that exceed 180 mg/dl. In conjunction with the pump attenuation algorithms, this article also proposes a system for alerting an individual of their hypoglycemic risk that contains three "levels" of alerts in the form of a traffic light. This alert system can be used in an advisory mode setting to alert the user to take action when hypoglycemia is imminent ("red" light) or in a closed-loop setting where initiation of rescue action begins when the red light alert is triggered.
Key Findings
1
Both algorithms dramatically reduce insulin delivery when impending hypoglycemia risk is high and can support closed-loop, open-loop, or advisory safety systems.
2
Hypoglycemia was defined according to the American Diabetes Association threshold of 70 mg/dl.
3
In simulations, Power Brakes reduced hypoglycemia incidence by 88% during elevated basal insulin delivery and by 94% after a meal bolus was given but the meal was skipped.
4
In the elevated-basal-rate scenario, hypoglycemia was not followed by rebounds above 180 mg/dl, the stated upper control limit.
5
Two insulin-attenuation algorithms were developed: Brakes uses continuous glucose monitoring alone, while Power Brakes additionally incorporates an insulin-informed metabolic state observer.
Research Object
insulin pump delivery systems using continuous glucose monitoring (CGM) and insulin pump data
Research Subject
pump-attenuation algorithms and traffic-light risk alerts for preventing hypoglycemia while maintaining glycemic control
Publication Details
Publication Date
2010-09-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
98
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by6
Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications2019
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp2013
Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges2016
Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis2013
Artificial Pancreas: Model Predictive Control Design from Clinical Experience2013
Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review2019